These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 27207408)

  • 1. Absence of the Effect of Pretransplant Body Mass Index on Post Kidney Transplant Outcomes.
    Tremblay S; Kaiser TE; Alloway RR; Woodle ES; Diwan TS
    Prog Transplant; 2016 Jun; 26(2):183-90. PubMed ID: 27207408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of underweight, overweight, and obese pediatric kidney transplant recipients.
    Kaur K; Jun D; Grodstein E; Singer P; Castellanos L; Teperman L; Molmenti E; Fahmy A; Frank R; Infante L; Sethna CB
    Pediatr Nephrol; 2018 Dec; 33(12):2353-2362. PubMed ID: 30136105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression.
    Schwartz JJ; Ishitani MB; Weckwerth J; Morgenstern B; Milliner D; Stegall MD
    Transplantation; 2007 Sep; 84(6):715-21. PubMed ID: 17893604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed allograft inflammation following alemtuzumab induction for kidney transplantation.
    Heilman RL; Khamash HA; Smith ML; Chakkera HA; Moss AA; Reddy KS
    Clin Transplant; 2013; 27(5):772-80. PubMed ID: 23924146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ; Duhart BT; Krauss AG; Moore LW; Egidi MF; Amiri HS; Gaber LW; Gaber AO
    Transplantation; 2008 Jul; 86(2):313-20. PubMed ID: 18645496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up.
    Ciancio G; Burke GW; Gaynor JJ; Roth D; Sageshima J; Kupin W; Tueros L; Hanson L; Rosen A; Ruiz P; Miller J
    Transplantation; 2008 Jul; 86(1):67-74. PubMed ID: 18622280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the recipient body mass index on the outcomes after kidney transplantation.
    Liese J; Bottner N; Büttner S; Reinisch A; Woeste G; Wortmann M; Hauser IA; Bechstein WO; Ulrich F
    Langenbecks Arch Surg; 2018 Feb; 403(1):73-82. PubMed ID: 28493145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Cumulative 6 mg/kg Antithymocyte Globulin on Early Posttransplant Outcomes in Kidney Transplant Recipients with Delayed Graft Function.
    Vu VA; Bhayana S; Sweiss H; Castro N; Hall R; Nelson J
    Prog Transplant; 2024 Jun; 34(1-2):47-52. PubMed ID: 38465633
    [No Abstract]   [Full Text] [Related]  

  • 9. Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients.
    Wojciechowski D; Chandran S; Vincenti F
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28190259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction Therapy With ATG Compared With Anti-IL2 Basiliximab in Low-Immunologic Risk Kidney Transplant Recipients.
    Dedinská I; Graňák K; Vnučák M; Skálová P; Laca Ĺ; Krivuš J; Galajda P; Mokáň M
    Transplant Proc; 2019 Dec; 51(10):3259-3264. PubMed ID: 31732198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal.
    Martin ST; Roberts KL; Malek SK; Tullius SG; Vadivel N; De Serres S; Grafals M; Elsanjak A; Filkins BA; Chandraker A; Gabardi S
    Pharmacotherapy; 2011 Jun; 31(6):566-73. PubMed ID: 21923440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early allograft biopsies performed during delayed graft function may not be necessary under thymoglobulin induction.
    Ortiz J; Parsikia A; Mumtaz K; Khanmoradi K; Balasubramanian M; Feyssa E; Campos S; Zaki R; Chewaproug D
    Exp Clin Transplant; 2012 Jun; 10(3):232-8. PubMed ID: 22631058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed Graft Function in Kidney Transplantation: Risk Factors and Impact on Early Graft Function.
    Tugmen C; Sert I; Kebabcı E; Murat Dogan S; Tanrısev M; Alparslan C; Kılıcaslan Ayna T; Olmez M; Karaca C
    Prog Transplant; 2016 Jun; 26(2):172-7. PubMed ID: 27207406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recipient Obesity and Kidney Transplant Outcomes: A Mate-Kidney Analysis.
    Sureshkumar KK; Chopra B; Josephson MA; Shah PB; McGill RL
    Am J Kidney Dis; 2021 Oct; 78(4):501-510.e1. PubMed ID: 33872689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Early Steroid Withdrawal in Recipients of Deceased-Donor Expanded Criteria Kidney Transplants in the Era of Induction Therapy.
    Hussain SM; Marcus RJ; Ko TY; Nashar K; Thai NL; Sureshkumar KK
    Exp Clin Transplant; 2016 Jun; 14(3):287-93. PubMed ID: 27221720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pretransplant body mass index on early kidney graft function.
    Kieszek R; Kwiatkowski A; Jędrzejko K; Domagała P; Bieniasz M; Wszoła M; Drozdrowski J; Tomaszek A; Gozdowska J; Zygier D; Pączek L; Durlik M; Chmura A
    Transplant Proc; 2014 Oct; 46(8):2689-91. PubMed ID: 25380895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal.
    Saull HE; Enderby CY; Gonwa TA; Wadei HM
    Clin Transplant; 2015 Jul; 29(7):573-80. PubMed ID: 25711849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti-T-lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction.
    Cantarovich D; Rostaing L; Kamar N; Saint-Hillier Y; Ducloux D; Mourad G; Garrigue V; Wolf P; Ellero B; Cassuto E; Albano L; Soulillou JP;
    Transpl Int; 2010 Mar; 23(3):313-24. PubMed ID: 19843296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of body mass index on graft survival in adult recipients transplanted with single pediatric kidneys.
    Balamuthusamy S; Paramesh A; Zhang R; Florman S; Shenava R; Islam T; Wagner J; Killackey M; Alper B; Simon EE; Slakey D
    Am J Nephrol; 2009; 29(2):94-101. PubMed ID: 18689988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.